Optimum outcomes
through a team approach
Today, the incidence of asthma and complicated airway
diseases in America is rising faster than nearly any other
chronic disease. Tackling diseases that so significantly
impact public health requires the most innovative clinical
thinking; and a dedication to discovering its underlying
causes.
In addition to providing state-of-the-art clinical care,
Yale-New Haven Hospital has teamed with Yale School
of Medicine to create a research hub where industry-sponsored and investigator-initiated studies are continually
underway. Our physicians in the Yale Center for Asthma
and Airways Disease are at the forefront of groundbreaking
research, such as studies that highlight the potential role
of the chitinase-like protein YKL- 40 as novel biomarkers in
asthma. This research suggests that this protein could be
useful to identify asthmatics or to characterize disease
severity. Other studies have focused on the pathogenesis
of refractory asthma, the vascular basis of asthma and the
natural history of asthma.
With their research as the backbone for providing exceptional treatments, our physicians are making life better
for our patients with complex airway diseases, and for
patients everywhere.
Yale-New Haven Hospital is the primary teaching
hospital of Yale School of Medicine. Pulmonology
services at Yale-New Haven was ranked 20th by
U.S.News & World Report in 2010-11.
www.ynhh.org
